Risk Materials

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Direct Communication to Non-HCP, Wholesalers and purchasing groups. Reformulation of Prenoxad 1mg/ml

Direct Communication to Non-medical practitioners involved in treatment services, Wholesalers and other direct purchasing groups. Prenoxad Injection (naloxone hydrochloride): reformulation to correct historic error in the expression of the strength; no changes in use or dosing schedule.

For Healthcare Professionals

Direct Communication to Non-HCPs, Wholesalers and purchasing groups. Prenoxad 0.91 mg/ml. Correction made to the Prenoxad Injection labelling.

Direct Communication to Non-medical practitioners involved in treatment services, Wholesalers and other direct purchasing groups on the correction made to the Prenoxad Injection following a historic error in the drug product labelling. Naloxone Hydrochloride, Prenoxad Injection, label correction

For Healthcare Professionals

Direct communication to patient, carers and community workers who have been supplied with Prenoxad Injection. Prenoxad 0.91 mg/ml

Direct communication to patient, carers and community workers who have been supplied with Prenoxad Injection Information regarding correcting the historic error on Prenoxad labelling.

Direct Communication to patients, carers and community workers who have been supplied with Prenoxad Injection. Reformulation of Prenoxad injection 1mg/ml

Direct Communication to patients, carers and community workers who have been supplied with Prenoxad Injection. Information regarding correcting an historic error in the Prenoxad formulation.

Send us feedback

If you would like to make a comment or send us feedback on this material, click here.